Umm... isn't it kinda suspicious that these results came out now? I mean, we're talking about the pharmaceutical industry here
. Can we get some info on how the trials were funded and who was involved? And what's with this 20% less likely to be diagnosed with dementia claim? How many people were in the study and what's the sample size?
Those numbers are always so important to verify.
And have we seen any data on long-term effects of taking Shingrix? Like, how many years is 20% less likely to be diagnosed with dementia exactly? And what about side effects? Are they being thoroughly looked into?
It's also a bit concerning that the funding for further research has dried up. What does this say about the priorities of the government and private investors? Shouldn't we be more cautious when it comes to investing in something like this, especially when there are so many unanswered questions
.
Oh, and one more thing - why aren't the results being published in a reputable scientific journal? It's always easy to see what's behind the curtain
.
why aren't pharmaceutical companies investing more in these studies? and what's with the low vaccination rates among certain groups 
i've got friends who are older and they're all super hesitant about getting vaccinated 
it's like we're creating a whole new generation of seniors with dementia before their time 